Straumann stock rises as Berenberg resumes coverage with a higher target

Published on 09/18/2026 at 15:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock gained around 0.5 percent to near 95.13 CHF on September 18, 2026 as Berenberg reinitiated coverage with a Buy rating and a 118 CHF price target. Goldman Sachs also upgraded Straumann to Buy on September 14, 2026, underscoring confidence in its dental implant growth story.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen — Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann Holding AG stock (ISIN CH0012280076) edged higher to about 95.13 CHF on SIX Swiss Exchange on September 18, 2026, supported by renewed analyst coverage and a higher price target from Berenberg alongside a recent upgrade by Goldman Sachs.

Analysts turn more positive on Straumann

According to Zonebourse on September 18, 2026, Berenberg restarted its research coverage of Straumann Holding with a Buy rating and highlighted the group’s dominant position in the global dental implant market.

German bank Berenberg set a price target of 118 CHF for Straumann stock, as reported by Finimize on September 18, 2026, implying upside of roughly 24 percent compared with the recent closing level of 94.66 CHF.

Recent price performance and trading range

Per price data from a Swiss stock portal, Straumann stock closed at 94.66 CHF on SIX Swiss Exchange on September 17, 2026, down 0.55 percent from the prior close of 95.18 CHF, with an intraday range between 94.60 CHF and 97.00 CHF and a trading volume of 264,117 shares.

During intraday trading on September 18, 2026, an estimate from Zonebourse placed Straumann around 95.13 CHF, corresponding to a gain of about 0.50 percent versus the previous day’s close and leaving the shares approximately 1.21 percent above their level at the start of 2026 and around 1.90 percent higher over the past five days.

52-week range and market capitalization

According to data summarized by Zonebourse, Straumann’s recent closing price of 94.66 CHF on September 17, 2026 stands more than 13 percent below a 52-week high of 109.80 CHF reached on July 1, 2026.

The same overview cites a consensus price target of 112.61 CHF, which is roughly 19 percent above the latest closing level, signalling that the average of covering analysts continues to see room for appreciation in Straumann stock.

Earnings expectations and fundamentals

Experts quoted by Finanzen.ch on September 17, 2026 expect Straumann to earn about 3.23 CHF per share in fiscal year 2026, providing a basis for valuation discussions as analysts update their models.

This projected earnings level compares with market-implied expectations embedded in the consensus target of 112.61 CHF, suggesting that Straumann trades at a forward price-earnings multiple that reflects both its growth prospects and its established position in dental implants and related technologies.

Goldman Sachs upgrade adds to positive tone

Zonebourse also notes that Goldman Sachs raised its recommendation on Straumann Holding to Buy on September 14, 2026, reinforcing the more constructive analyst stance toward the stock.

With both Berenberg and Goldman Sachs now advocating a positive view, Straumann benefits from a strengthened analyst backdrop that could support the shares if upcoming quarterly results confirm the expected earnings trajectory and demand trends in implants, scanners and clear aligners.

Next earnings date and investor focus

According to the agenda section in the Zonebourse overview cited above, Straumann is scheduled to publish its results for the third quarter of 2026 on October 28, 2026, marking the next key checkpoint for investors following the stock.

Until that date, the market is likely to focus on whether Straumann can sustain mid-single-digit or higher revenue growth while defending margins in its core implant business, a theme that Berenberg highlighted when it described the company’s position as dominant in dental implants.

Straumann stock price as of the last close

At the close of trading on September 17, 2026, Straumann stock finished at 94.66 CHF on SIX Swiss Exchange, representing the most recent completed reference price for the shares and serving as the benchmark level against which the latest analyst targets and intraday moves on September 18, 2026 are being assessed.